MedTrace Logo

The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients

NCT02306239 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-12-30

No results posted yet for this study

Summary

Terlipressin becomes a vasopressin for septic shock. But some studies found it may lead to severe intesitnal complications such as intestinal ischemia. The investigators study was designed to find the effect of terlipressin on intestinal function in septic shock patients.

Conditions

  • Terlipressin
  • Septic Shock

Interventions

DRUG

Terlipressin

DRUG

Norepinephrine

Sponsors & Collaborators

  • Liu ZiMeng

    lead OTHER

Principal Investigators

  • liu zimeng, master · the first affiliated hospital of SUMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02306239 on ClinicalTrials.gov